ANNA KRYUCHINA: Open Payments
NPI 1790210524 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,601 in 44 payments from 11 companies in 2025. Trend: 2023 $1,719 · 2024 $1,640 · 2025 $2,601
Food & beverage: $2,601
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $712 |
| UCB, Inc. | 8 | $634 |
| Lilly USA, LLC | 2 | $222 |
| Organon LLC | 7 | $211 |
| Janssen Biotech, Inc. | 4 | $206 |
| ABBVIE INC. | 4 | $180 |
| Galderma Laboratories, L.P. | 2 | $141 |
| Incyte Corporation | 1 | $123 |
| Arcutis Biotherapeutics, Inc. | 5 | $97 |
| Almirall LLC | 2 | $40 |
Products named: Bimzelx, DUPIXENT, EBGLYSS, VTAMA, TREMFYA, SKYRIZI, LIBTAYO, NEMLUVIO.
Industry payments across AZ — which companies pay providers there.
